MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
$5,741,100K
(-7.58%↓ Y/Y)
Marketable securities
$5,487,100K
(-15.90%↓ Y/Y)
Inventories
$3,200,800K
(3.68%↑ Y/Y)
Cash and cash
equivalents
$3,118,100K
(25.32%↑ Y/Y)
Prepaid expenses and
other current assets
$474,800K
(35.97%↑ Y/Y)
Total current assets
$18,021,900K
(-3.42%↓ Y/Y)
Marketable securities
$10,260,600K
(15.29%↑ Y/Y)
Property, plant, and
equipment, net
$5,120,400K
(11.32%↑ Y/Y)
Deferred tax assets
$4,077,200K
(23.03%↑ Y/Y)
Other noncurrent
assets
$1,821,200K
(60.32%↑ Y/Y)
Intangible assets, net
$1,257,400K
(9.47%↑ Y/Y)
Total assets
$40,558,700K
(7.41%↑ Y/Y)
Total liabilities and
stockholders' equity
$40,558,700K
(7.41%↑ Y/Y)
Total stockholders'
equity
$31,256,900K
(6.48%↑ Y/Y)
Total liabilities
$9,301,800K
(10.66%↑ Y/Y)
Treasury stock, at cost
33.7 shares in 2025...
$18,612,800K
(22.72%↑ Y/Y)
Retained earnings
$35,797,100K
(13.02%↑ Y/Y)
Total current
liabilities
$4,368,400K
(10.75%↑ Y/Y)
Other noncurrent
liabilities
$2,018,800K
(28.47%↑ Y/Y)
Long-term debt
$1,985,900K
(0.08%↑ Y/Y)
Finance lease
liabilities
$720,000K
(0.00%↑ Y/Y)
Deferred revenue
$208,700K
(12.39%↑ Y/Y)
Additional paid-in capital
$13,995,000K
(8.86%↑ Y/Y)
Accumulated other
comprehensive income (loss)
$77,500K
(1081.01%↑ Y/Y)
Common stock-Common
Stock
$100K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$2,876,400K
(13.82%↑ Y/Y)
Accounts payable
$939,000K
(18.94%↑ Y/Y)
Deferred revenue
$553,000K
(-11.90%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)